Plymouth Hospitals NHS Trust
Plymouth, United Kingdom
1 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 2
MEN1703 (SEL24) to Treat Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma (JASPIS-01)
Ryvu Therapeutics SA178 enrolled36 locationsNCT06534437
Recruiting
Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
CHDI Foundation, Inc.35,000 enrolled183 locationsNCT01574053